Corner Therapeutics
MA - Watertown
Biotechnology1 H-1B visas (FY2023)Focus: Dendritic cell hyperactivation (hDC) platform, inflammasomes
Corner Therapeutics is a life sciences company focused on Dendritic cell hyperactivation (hDC) platform, inflammasomes.
Open Jobs
0
Products & Portfolio (2)
Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Portfolio: 2 approved products
H-1B (2023): 1 approval
Portfolio Health
Post-LOE2 (100%)
2 total products
Hiring Trend
Stable
0
Open Roles
+0
Added
-0
Filled/Removed
Based on last 4 crawl cycles
Visa Sponsorship
Sponsors Work Visas
H-1B Petitions (FY2023)
1
Approved
0
Denied
100%
Rate
Source: USCIS H-1B Employer Data Hub